Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes

NCT02512042 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

973

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Test-Brinzolamide 1% Ophthalmic suspension
DRUG: Reference-Brinzolamide 1% Ophthalmic suspension

Sponsor

Actavis Inc.